CPhI Worldwide Announces Finalists of Largest Ever Pharma Awards

Article

 

CPhI Worldwide, organized by UBM (part of Informa PLC), has announced the finalists of the eagerly anticipated 2018 CPhI Pharma Awards.

This year’s edition features a record breaking number of entries, with over 250 from 174 participating companies across 17 categories, commending the innovations, technologies, and strategies driving pharma forward.

Such was the high caliber of entrants, 139 have been shortlisted, with the winners due to be announced during a live awards ceremony taking place at the luxurious Eurostars Madrid Tower Hotel on Tuesday October 9 – the opening day of CPhI Worldwide.

Innovations across flow chemistry, single-use technologies, drug delivery devices, contract services and packaging were amongst many shortlisted, with the judges concluding this was by far the highest ever standard of entries – further cementing 2018 as the year of innovation in pharma.

The awards for “Pharma company of the year”and “CEO of the year” will again be keenly sought as over 45,000 senior executives and 2500 companies attend at this year’s CPhI Worldwide.

To see the complete list of finalists, please visit https://awards.cphi.com/finalists/. The awards will be presented at the CPhI Awards Gala with over 350 guests in attendance.

To reserve a table for the CPhI Pharma Awards Gala, please visit https://awards.cphi.com/attend-the-gala/. 

 

Recent Videos
Fred Aslan
Gameto - Addressing Regulatory Hurdles in iPSC-Based Fertility
Fred Aslan
Dr. Dina Radenkovic, CEO, Gameto
Recent Regulatory Impacts on the Pain-Management Space
Fred Aslan
Fred Aslan
Related Content
Azurity Pharmaceuticals Completes Covis Pharma Acquisition

Azurity Pharmaceuticals Completes Covis Pharma Acquisition

Don Tracy, Associate Editor
March 14th 2025
Article

Deal to acquire Covis is expected to expand Azurity’s portfolio across multiple complex dosage forms and key therapeutics areas.

Navigating Distrust: Pharma in the Age of Social Media

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
February 18th 2025
Podcast

Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.

High Impact

High Impact

Mike Hennessy Jr.
March 14th 2025
Article

As coverage in Pharmaceutical Executive’s March issue reinforces, AI's connections and permutations are seemingly touching all parts of the industry—and only growing.

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Stock.adobe.com

Corporate Versus Tradition: A Discussion on Venture Innovation

Mike Hollan
March 14th 2025
Article

A panel discussion at the Global Life Science Partnering and Investor Conference discusses various strategies and trends in pharma investing.

Real-World Data Demonstrates Efficacy of Apretude and Cabenuva in HIV Prevention, Treatment

Real-World Data Demonstrates Efficacy of Apretude and Cabenuva in HIV Prevention, Treatment

Don Tracy, Associate Editor
March 14th 2025
Article

New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and treatment, with Apretude showing zero HIV acquisitions and Cabenuva maintaining high viral suppression rates.